Antiviral activity of molnupiravir against COVID-19: a schematic review of evidences

被引：7
|
作者：
Shivali Singla
Sachin Goyal
机构：
[1] Abhilashi University,Department of Pharmaceutics, School of Pharmacy
来源：
Bulletin of the National Research Centre | / 46卷 / 1期
关键词：
Molnupiravir; EIDD-2801; EIDD-1931; COVID-19; SARS-Cov-2;
D O I：
10.1186/s42269-022-00753-9
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [41] Molnupiravir: A new candidate for COVID-19 treatment
    Pourkarim, Fariba
    Pourtaghi-Anvarian, Samira
    Rezaee, Haleh
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
  • [42] Fight against COVID-19: The case of antiviral surfaces
    Shirvanimoghaddam, Kamyar
    Akbari, Mohammad Karbalaei
    Yadav, Ram
    Al-Tamimi, Adil K.
    Naebe, Minoo
    APL MATERIALS, 2021, 9 (03)
  • [43] Current Perspective of Antiviral Strategies against COVID-19
    Ahidjo, Bintou A.
    Loe, Marcus Wing Choy
    Ng, Yan Ling
    Mok, Chee Keng
    Chu, Justin Jang Hann
    ACS INFECTIOUS DISEASES, 2020, 6 (07): : 1624 - 1634
  • [44] Audio Interview: A New Antiviral against Covid-19
    Rubin, Eric J.
    Baden, Lindsey R.
    Morrissey, Stephen
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07):
  • [45] Scoping insight on antiviral drugs against COVID-19
    Ali, Ahmed S.
    Ibrahim, Ibrahim M.
    Burzangi, Abdulhadi S.
    Ghoneim, Ragia H.
    Aljohani, Hanin S.
    Alsamhan, Hamoud A.
    Barakat, Jehan
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (10)
  • [46] Potential of graphene based photocatalyst for antiviral activity with emphasis on COVID-19: A review
    Patial, Shilpa
    Kumar, Abhinandan
    Raizada, Pankaj
    Van Le, Quyet
    Nguyen, Van-Huy
    Selvasembian, Rangabhashiyam
    Singh, Pardeep
    Thakur, Sourbh
    Hussain, Chaudhery Mustansar
    JOURNAL OF ENVIRONMENTAL CHEMICAL ENGINEERING, 2022, 10 (03):
  • [47] Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
    Formiga, Fabio Rocha
    Leblanc, Roger
    Reboucas, Juliana de Souza
    Farias, Leonardo Paiva
    de Oliveira, Ronaldo Nascimento
    Pena, Lindomar
    JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 758 - 761
  • [48] Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [49] Vaccines Against COVID-19: A Review
    Torres-Estrella, Carlos U.
    del Rocio Reyes-Montes, Maria
    Duarte-Escalante, Esperanza
    Sierra Martinez, Monica
    Guadalupe Frias-De-Leon, Maria
    Acosta-Altamirano, Gustavo
    VACCINES, 2022, 10 (03)
  • [50] Polymorphs, Particle Size, and a Pandemic: Development of a Scalable Crystallization Process for Molnupiravir, an Antiviral for the Treatment of COVID-19
    Bade, Rachel
    Bothe, Jameson R.
    Sirota, Eric
    Brunskill, Andrew P. J.
    Newman, Justin A.
    Zhang, Yongqian
    Tan, Melissa
    Zheng, Michelle
    Brito, Gilmar
    Poirier, Marc
    Fier, Patrick S.
    Xu, Yingju
    Ward, Michael D.
    Stone, Kevin
    Lee, Ivan H.
    Gmitter, Andrew J.
    Bernardoni, Frank
    Zompa, Michael A.
    Luo, Hanlin
    Patel, Sanjaykumar
    Masiuk, Tina
    Mora, Jeff
    Ni, Tong
    Okoh, Grace A.
    Tarabokija, James
    Liu, Jiaying
    Lowinger, Michael B.
    Mahmood, Tariq
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (11) : 2100 - 2110
12345